Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
18 May 2016 Three Generations of Cancer Immunotherapies Cancer Immunology and Immunotherapy
13 May 2016 Can Regulators Influence the Affordability of Medicines? Bioethics, legal and economic issues
12 May 2016 Anti-Proliferative Effect and Predictive Biomarkers to Palbociclib in Early Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
11 May 2016 Microwave Ablation for Treating Liver Metastases Gastrointestinal cancers
10 May 2016 Residual Disease in Oncogene-Driven Solid Tumours Anticancer agents & Biologic therapy
09 May 2016 Imatinib in the context of the anticancer immunosurveillance system Anticancer agents & Biologic therapy
06 May 2016 EMA Recommends Granting a Marketing Authorisation for Lutetium (177 Lu) Chloride Imaging - Endocrine cancers
04 May 2016 EMA Recommends Extending the Authorised Indications for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
03 May 2016 EMA Adopts a New Indication for Everolimus Endocrine cancers - Anticancer agents & Biologic therapy
02 May 2016 EMA Adopts a New Indication for Bevacizumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Apr 2016 Mucinous Colorectal Cancer Pathology/Molecular biology - Gastrointestinal cancers
25 Apr 2016 Integrating Patients’ Views in Clinical Studies of Anticancer Medicines Anticancer agents & Biologic therapy
19 Apr 2016 Microbiota in Colorectal Cancer Basic science - Gastrointestinal cancers
18 Apr 2016 FDA Approves Venetoclax for CLL in Patients With 17p Deletion Who Have Been Treated With at Least One Prior Therapy Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Osimertinib Combined With Durvalumab in EGFR-mutant Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy